Fundacio Institut D’Investigacio Biomedica De Bellvitge IDIBELL

Oncology and tumour immunotherapy

Solid tumours are a major focus, including advanced solid tumours, germ cell tumours, metastatic uveal melanoma, and cutaneous squamous cell carcinoma. The portfolio also includes studies in tumour immune resistance and anti-PD-1 therapy.

  • Advanced solid tumours
  • Germ cell tumours
  • Metastatic uveal melanoma
  • Cutaneous squamous cell carcinoma

Research activity in this area includes cell-based immunotherapy, tumour response assessment, and the study of biomarkers linked to treatment resistance.

Renal medicine and transplantation

Several trials address kidney transplantation and related complications, including post-transplant diabetes, graft pyelonephritis, metabolic syndrome in transplant candidates, and latent tuberculosis infection in people with end-stage kidney disease.

  • Kidney transplantation
  • Post-transplant diabetes
  • Graft pyelonephritis
  • Latent tuberculosis infection

The sponsor also studies metabolic risk in transplant populations and infection-related outcomes in renal care.

Neuromuscular and rare neurological disease

Investigator interest extends to rare and chronic neurological disorders such as adrenomyeloneuropathy, generalized myasthenia gravis, and Type C Niemann-Pick disease, with attention to both functional symptoms and cognitive impairment.

  • Adrenomyeloneuropathy
  • Generalized myasthenia gravis
  • Type C Niemann-Pick disease

These studies reflect interest in neuromuscular weakness, neurodegeneration, and disease-related disability.

Respiratory and lymphatic disorders

The sponsor funds research in lymphangioleiomyomatosis, a rare progressive lung disease, including work related to symptom control and treatment safety in combination with established therapies.

  • Lymphangioleiomyomatosis

This area links pulmonary disease with rare-disease management and long-term therapeutic monitoring.

Infectious disease prevention and mental health

Additional studies cover HPV infectivity and transmission, HPV vaccination, and treatment of major depressive disorder with moderate to severe insomnia.

  • Human papillomavirus infection and vaccination
  • Major depressive disorder with insomnia

These topics include infection prevention, sleep disturbance, and psychiatric symptom management.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Comparing the effectiveness of 7 days versus 14 days of ciprofloxacin or ceftriaxone for treating kidney infection in kidney transplant recipients

    Recruiting

    3 1 1 1
    Investigated diseases:
    Spain
  • Study on Efgartigimod for Early Treatment in Patients with Generalized Myasthenia Gravis

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study on Reducing HPV Infectivity in HPV-Positive Women Using 9vHPV Vaccine

    Recruiting

    3 1 1 1
    Spain
  • Daridorexant for Insomnia in Patients with Major Depressive Disorder and Moderate to Severe Insomnia

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Spain
  • A study of cemiplimab in patients with locally advanced cutaneous squamous cell carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain
  • Study of Autologous Tumor-Infiltrating Lymphocytes with Cyclophosphamide, Fludarabine and Aldesleukin in Patients with Germ Cell Tumors

    Not yet recruiting

    2 1 1 1
    Spain